Page 32 - Read Online
P. 32

Page 14 of 19            Khokhar et al. Mini-invasive Surg 2022;6:2  https://dx.doi.org/10.20517/2574-1225.2021.97

               Conflicts of interest
               Mangieri A & Dudek D received scientific grant from Boston Scientific Inc. Other authors declared that
               there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2022.

               REFERENCES
               1.       Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the
                    Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60:1438-54.  DOI  PubMed
               2.       Généreux P, Webb JG, Svensson LG, et al; PARTNER Trial Investigators. Vascular complications after transcatheter aortic valve
                    replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol 2012;60:1043-52.
                    DOI  PubMed
               3.       Arnold SV, Zhang Y, Baron SJ, et al. Impact of short-term complications on mortality and quality of life after transcatheter aortic
                    valve replacement. JACC Cardiovasc Interv 2019;12:362-9.  DOI  PubMed  PMC
               4.       Ueshima D, Fovino LN, D'Amico G, Brener SJ, Esposito G, Tarantini G. Transcatheter versus surgical aortic valve replacement in
                    low- and intermediate-risk patients: an updated systematic review and meta-analysis. Cardiovasc Interv Ther 2019;34:216-25.  DOI
                    PubMed
               5.       Rahhab Z, Ramdat Misier K, El Faquir N, et al. Vascular complications after transfemoral transcatheter aortic valve implantation: a
                    systematic review and meta-analysis. Structural Heart 2020;4:62-71.  DOI
               6.       Mack MJ, Leon MB, Thourani VH, et al; PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-
                    expandable valve in low-risk patients. N Engl J Med 2019;380:1695-705.  DOI  PubMed
               7.       Popma JJ, Deeb GM, Yakubov SJ, et al; Evolut Low Risk Trial Investigators. Transcatheter aortic-valve replacement with a self-
                    expanding valve in low-risk patients. N Engl J Med 2019;380:1706-15.  DOI  PubMed
               8.       Blanke P, Weir-McCall JR, Achenbach S, et al. Computed tomography imaging in the context of transcatheter aortic valve
                    implantation  (TAVI)  /  transcatheter  aortic  valve  replacement  (TAVR):  an  expert  consensus  document  of  the  Society  of
                    Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr 2019;13:1-20.  DOI  PubMed
               9.       Mangieri A, Laricchia A, Montalto C, et al. Patient selection, procedural planning and interventional guidance for transcatheter aortic
                    valve intervention. Minerva Cardiol Angiol 2021;69:671-83.  DOI  PubMed
               10.       Francone M, Budde RPJ, Bremerich J, et al. CT and MR imaging prior to transcatheter aortic valve implantation: standardisation of
                    scanning protocols, measurements and reporting-a consensus document by the European Society of Cardiovascular Radiology
                    (ESCR). Eur Radiol 2020;30:2627-50.  DOI  PubMed  PMC
               11.       Junquera L, Urena M, Latib A, et al. Comparison of transfemoral versus transradial secondary access in transcatheter aortic valve
                    replacement. Circ Cardiovasc Interv 2020;13:e008609.  DOI  PubMed
               12.       Allende R, Urena M, Cordoba JG, et al. Impact of the use of transradial versus transfemoral approach as secondary access in
                    transcatheter aortic valve implantation procedures. Am J Cardiol 2014;114:1729-34.  DOI  PubMed
               13.       Di Mario C, Goodwin M, Ristalli F, et al. A prospective registry of intravascular lithotripsy-enabled vascular access for transfemoral
                    transcatheter aortic valve replacement. JACC Cardiovasc Interv 2019;12:502-4.  DOI  PubMed
               14.       Faroux L, Junquera L, Mohammadi S, et al. Femoral versus nonfemoral subclavian/carotid arterial access route for transcatheter
                    aortic valve replacement: a systematic review and meta-analysis. J Am Heart Assoc 2020;9:e017460.  DOI  PubMed  PMC
               15.       Beurtheret S, Karam N, Resseguier N, et al. Femoral versus nonfemoral peripheral access for transcatheter aortic valve replacement. J
                    Am Coll Cardiol 2019;74:2728-39.  DOI  PubMed
               16.       Dahle TG, Kaneko T, McCabe JM. Outcomes following subclavian and axillary artery access for transcatheter aortic valve
                    replacement: Society of the Thoracic Surgeons/American College of Cardiology TVT Registry Report. JACC Cardiovasc Interv
                    2019;12:662-9.  DOI  PubMed
               17.       Greenbaum AB, Babaliaros VC, Chen MY, et al. Transcaval access and closure for transcatheter aortic valve replacement: a
                    prospective investigation. J Am Coll Cardiol 2017;69:511-21.  DOI  PubMed  PMC
               18.       Lederman RJ, Babaliaros VC, Rogers T, et al. The fate of transcaval access tracts: 12-month results of the prospective NHLBI
                    transcaval transcatheter aortic valve replacement study. JACC Cardiovasc Interv 2019;12:448-56.  DOI  PubMed  PMC
               19.       Elbaz-Greener  G,  Zivkovic  N,  Arbel  Y,  Radhakrishnan  S,  Fremes  SE,  Wijeysundera  HC.  Use  of  two-dimensional
                    ultrasonographically guided access to reduce access-related complications for transcatheter aortic valve replacement. Can J Cardiol
                    2017;33:918-24.  DOI  PubMed
   27   28   29   30   31   32   33   34   35   36   37